BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35837992)

  • 1. Multi-center evaluation of the highly sensitive Abbott ARCHITECT and Alinity thyroglobulin chemiluminescent microparticle immunoassay.
    Evans C; Lotz J; Bhandari M; Hellier RT; Wang XY; Lott R; Lackner KJ; Müller R; Kulasingam V
    J Clin Lab Anal; 2022 Sep; 36(9):e24595. PubMed ID: 35837992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre clinical evaluation of the new highly sensitive Elecsys® thyroglobulin II assay in patients with differentiated thyroid carcinoma.
    Trimboli P; Imperiali M; Piccardo A; CampennÌ A; Giordani I; Ruggeri RM; Baldari S; Orlandi F; Giovanella L
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):295-302. PubMed ID: 28960391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the new Abbott®Alinity assay for the measurement of thyroglobulin antibodies in patients with differentiated thyroid carcinoma.
    Garcia Cano AM; Rosillo Coronado M; Alcázar García L; Gómez Lozano A; Carrasco Sayalero A; Rodriguez Torres A
    Ann Clin Biochem; 2023 Mar; 60(2):136-141. PubMed ID: 36653316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between a new thyroglobulin assay with the well-established Beckman Access immunoassay: A preliminary report.
    Cennamo M; La Civita E; Curci A; Liotti A; Braschi U; Terracciano D
    J Clin Lab Anal; 2021 Feb; 35(2):e23589. PubMed ID: 32951246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the highly sensitive Roche thyroglobulin II assay and establishment of a reference limit for thyroglobulin-negative patient samples.
    Rotteveel-de Groot DM; Ross HA; Janssen MJR; Netea-Maier RT; Oosting JD; Sweep FCGJ; van Herwaarden AE
    Pract Lab Med; 2016 Aug; 5():6-13. PubMed ID: 28856198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes of discordance between thyroglobulin antibody assays.
    Pickett AJ; Jones M; Evans C
    Ann Clin Biochem; 2012 Sep; 49(Pt 5):463-7. PubMed ID: 22829697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Abbott Alinity i Thyroid-Stimulating Hormone Receptor Antibody (TRAb) Chemiluminescent Microparticle Immunoassay (CMIA).
    Lee DJW; Phua SK; Liang Y; Chen C; Aw TC
    Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627966
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a new automated assay for high-sensitivity thyroglobulin measurement and comparison with two established high-sensitivity thyroglobulin assays.
    Broecker-Preuss M; Mehnert I; Gilman E; Herrmann K; Weber M; Görges R
    Pract Lab Med; 2021 Aug; 26():e00250. PubMed ID: 34386567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
    Boi F; Baghino G; Atzeni F; Lai ML; Faa G; Mariotti S
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1364-9. PubMed ID: 16434461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical irrelevance of lower titer thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma.
    Dekker BL; van der Horst-Schrivers ANA; Brouwers AH; Shuford CM; Kema IP; Muller Kobold AC; Links TP
    Eur Thyroid J; 2022 Dec; 11(6):. PubMed ID: 36169927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric reference interval verification for 17 specialized immunoassays and cancer markers on the Abbott Alinity i system in the CALIPER cohort of healthy children and adolescents.
    Bohn MK; Wilson S; Schneider R; Massamiri Y; Randell EW; Adeli K
    Clin Chem Lab Med; 2023 Jan; 61(1):123-132. PubMed ID: 36117243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical and clinical performance of thyroglobulin autoantibody assays in thyroid cancer follow-up.
    Katrangi W; Grebe SKG; Algeciras-Schimnich A
    Clin Chem Lab Med; 2017 Oct; 55(12):1987-1994. PubMed ID: 28672730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric reference interval verification for common biochemical assays on the Abbott Alinity system.
    Bohn MK; Wilson S; Hall A; Massamiri Y; Randell E; Adeli K
    Clin Chem Lab Med; 2021 Aug; 59(9):1554-1562. PubMed ID: 34008378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of changing thyroglobulin and antithyroglobulin antibodies analytical methods in the follow-up of patients with differentiated thyroid carcinoma.
    Deza S; Maroto J; Tellechea O; Orbegozo N; Merino J; Galofré JC; Alegre E; González Á
    Clin Chim Acta; 2023 Aug; 548():117502. PubMed ID: 37516333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.
    Iervasi A; Iervasi G; Ferdeghini M; Solimeo C; Bottoni A; Rossi L; Colato C; Zucchelli GC
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):434-41. PubMed ID: 17555505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, characterization and clinical validation of new sensitive immunofluorometric assay for the measurement of serum thyroglobulin.
    Nakabashi CC; Biscolla RP; Kasamatsu TS; Tachibana TT; Barcelos RN; Malouf EZ; Andreoni DM; Maciel RM; Vieira JG
    Arq Bras Endocrinol Metabol; 2012 Dec; 56(9):658-65. PubMed ID: 23329190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of thyroglobulin measurement with fine-needle aspiration biopsy for lymph node metastases in patients with a history of differentiated thyroid cancer.
    Zhang HS; Wang RJ; Fu QF; Gao S; Sun BT; Sun H; Ma QJ
    Asian Pac J Cancer Prev; 2014; 15(24):10905-9. PubMed ID: 25605199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Thyroglobulin Immunoassay Using the Specimen-Pretreatment Process Improves the Accuracy of Thyroglobulin Measurements in Anti-Thyroglobulin Positive Specimens.
    Kitamura Y; Narita S; Kuroda Y; Yagi S; Aoyagi K
    J Appl Lab Med; 2021 Nov; 6(6):1463-1475. PubMed ID: 34580727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.